PATH-68 Clinical and molecular features of synchronous and metachronous primary brain tumors
Abstract
Primary brain tumors (PBTs) are uncommon among the general population. Molecularly distinct PBTs in the same individual are even rarer and generally occur in the context of specific well-characterized hereditary cancer syndromes or in exposure to high-risk environmental factors such as remote CNS irradiation. In the absence of these risk factors, patients having 2 or more different primary brain tumors are exceedingly rare. Retrospective review at MD Anderson Cancer Center between 07/2020 through 08/2025 was performed to identify patients with at least 2 distinct PBTs of different histologic and molecular features during various times of their treatment. Tumor tissue was analyzed by next-generation sequencing. Overall survival (OS) was defined as the time between diagnosis of first known PBT to death. There were 10 cases identified in this series. Tumor types included astrocytoma, oligodendroglioma, glioblastoma, ependymoma, medulloblastoma, and meningioma. Age range at initial PBT diagnosis ranged from 4 to 54 years. Six of 10 patients were female. Three patients in the cohort remain alive at last follow-up with average OS of 6.7 years, and 4 patients were deceased after ∼14 years since initial PBT. Three cases were lost to follow-up after a second opinion or initial treatment, and long-term survival data is unavailable. In terms of putative risk factors: two patients had pathogenic germline mutations identified in NF1 and CDKN2A; 1 patient had known exposure to radiation as a child (for treatment of medulloblastoma) and subsequently developed PBTs in adulthood. Multiple molecularly distinct multiple PBTs are exceedingly rare in patients without clear genetic or environmental predispositions. While germline mutations (NF1, CDKN2A) and prior radiation explain some of these rare cases, many seem to occur sporadically. As such, additional work should be done to identify risk factors that predispose to multiple PBTs and characterize outcomes in these instances.